NCT01706835 2022-02-10Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid TumorsImmunityBio, Inc.Phase 1 Completed18 enrolled